Nippon India Pharma Fund-Growth Plan-Growth Option: NAV & Returns

Nippon India Pharma Fund-Growth Plan-Growth Option is a Sector - Healthcare mutual fund from Nippon India Mutual Fund, benchmarked against BSE Healthcare TR INR, launched in June 2004. As on the latest data it manages around ₹7,898.24 crore with an expense ratio of 1.52%.

Latest NAV

₹530.3524

As on 3 Jun 2026

1Y Return

+5.6%

absolute

3Y Return

+21.5%

annualised (CAGR)

5Y Return

+12.5%

annualised (CAGR)

Risk: Very High Risk
Fund house: Nippon India Mutual FundFund manager: Sailesh Raj Bhan, Kinjal Desai, Amber SinghaniaCategory: Sector - HealthcareBenchmark: BSE Healthcare TR INRAUM: ₹7,898.24 CrExpense ratio: 1.52%Launched: Jun 2004ISIN: INF204K01968

NAV History (since launch)

Trailing Returns

PeriodReturnBasis
1M+1.3%Absolute
3M+4.8%Absolute
6M+3.1%Absolute
1Y+5.6%Absolute
3Y+21.5%Annualised (CAGR)
5Y+12.5%Annualised (CAGR)
Since launch+17.5%Annualised (CAGR)

Top 10 Holdings

39 stocks in portfolio
StockSectorWeight
Sun Pharmaceuticals Industries LtdHealthcare13.85%
Lupin LtdHealthcare7.95%
Dr Reddy's Laboratories LtdHealthcare7.04%
Divi's Laboratories LtdHealthcare6.61%
Cipla LtdHealthcare5.47%
Apollo Hospitals Enterprise LtdHealthcare5.01%
Medplus Health Services LtdHealthcare3.78%
Vijaya Diagnostic Centre LtdHealthcare3.36%
Sai Life Sciences LtdHealthcare3.27%
Ajanta Pharma LtdHealthcare3.19%

Sector Allocation

Healthcare98.7%

Market Cap Allocation

Large cap41.1%
Mid cap27.8%
Small cap30.1%
Others / cash1.1%

Equity 98.7% · Debt 0.0% · Cash 1.3%

Back-test a SIP in this fundOpen in NAV explorerCompare with other funds

NAV data sourced from public AMFI feeds via mfapi.in and finapi.upvaly.com. Latest NAV as on 3 Jun 2026.

Understanding Nippon India Pharma Fund-Growth Plan-Growth Option

The NAV shown above is the per-unit price of Nippon India Pharma Fund-Growth Plan-Growth Option, declared after market hours on each business day. It is already net of the fund's expense ratio, so the returns calculated from it reflect what an investor actually earned. Returns up to one year are shown as absolute figures, while three-year, five-year and since-launch returns are annualised (CAGR), which is the standard way longer-term performance is reported.

This page tracks the Regular plan. To judge the fund, look at its longer-term returns and how steadily the NAV has grown rather than any single year. You can back-test a SIP in this fund to see what a monthly investment would have grown to, or compare it with other Sector - Healthcare funds before deciding. Whether it suits you depends on your goal, time horizon and risk appetite, so speak to your mutual fund distributor before investing.

Frequently Asked Questions

NAV and returns are factual historical data for information only and are not a recommendation to buy, sell or hold this scheme. Past performance is not indicative of future results. Returns are before exit load and taxes. Mutual Fund investments are subject to market risks; read all scheme related documents carefully before investing. Consult your mutual fund distributor before investing.